• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ClearPoint Neuro Inc. - Common Stock (NQ:CLPT)

15.38 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,188
Open 15.38
Bid (Size) 13.00 (400)
Ask (Size) 13.16 (200)
Prev. Close 15.38
Today's Range 15.38 - 15.38
52wk Range 8.270 - 30.10
Shares Outstanding 23,639,616
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
ClearPoint Neuro Q2 Earnings Call Highlights ↗
August 03, 2026
ClearPoint Neuro (NASDAQ:CLPT) reported second-quarter 2026 revenue growth while outlining a shift in investment priorities toward clinical capacity, preclinical laboratory services and technologies... 
Via MarketBeat
Topics Earnings
Stay updated with the stocks that are on the move in today's after-hours session. ↗
August 03, 2026
Via Chartmill

Performance

YTD
+9.6%
+9.6%
1 Month
-14.6%
-14.6%
3 Month
+37.6%
+37.6%
6 Month
+16.2%
+16.2%
1 Year
+46.1%
+46.1%

More News

Read More
News headline image
ClearPoint Neuro Reports Second Quarter 2026 Results
August 03, 2026
From ClearPoint Neuro, Inc.
Via ACCESS Newswire
News headline image
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel
July 31, 2026
From ClearPoint Neuro, Inc.
Via ACCESS Newswire
News headline image
ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026
July 21, 2026
From ClearPoint Neuro, Inc.
Via ACCESS Newswire
ClearPoint Neuro Inc (NASDAQ:CLPT) Reports Q4 2025 Revenue Beat Amid Widened Loss, Shares Fall ↗
March 17, 2026
Via Chartmill
These stocks are moving in today's session ↗
June 17, 2026
Via Chartmill
Gapping stocks in Wednesday's session ↗
June 17, 2026
Via Chartmill
Discover the top movers in Wednesday's pre-market session. ↗
June 17, 2026
Via Chartmill
News headline image
ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint
May 27, 2026
Via ACCESS Newswire
News headline image
ClearPoint Neuro Q1 Earnings Call Highlights ↗
May 13, 2026
Via MarketBeat
Topics Earnings
News headline image
ClearPoint (CLPT) Q1 2026 Earnings Transcript ↗
May 13, 2026
Via The Motley Fool
News headline image
ClearPoint Neuro Reports First Quarter 2026 Results
May 13, 2026
Via ACCESS Newswire
News headline image
ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint
May 13, 2026
Via ACCESS Newswire
News headline image
ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026
April 29, 2026
Via ACCESS Newswire
News headline image
ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint
April 22, 2026
Via ACCESS Newswire
News headline image
ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint
April 20, 2026
Via ACCESS Newswire
News headline image
ClearPoint Neuro (CLPT) Earnings Call Transcript ↗
March 17, 2026
Via The Motley Fool
Topics Earnings
News headline image
ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results
March 17, 2026
Via ACCESS Newswire
News headline image
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026
March 06, 2026
Via ACCESS Newswire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
March 02, 2026
Via Chartmill
Get insights into the top gainers and losers of Monday's pre-market session. ↗
March 02, 2026
Via Chartmill
News headline image
ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue
January 12, 2026
Via ACCESS Newswire
News headline image
ClearPoint Neuro Completes Acquisition of IRRAS
November 20, 2025
Via ACCESS Newswire
News headline image
ClearPoint Neuro Reports Third Quarter 2025 Results
November 06, 2025
Via ACCESS Newswire

Frequently Asked Questions

Is ClearPoint Neuro Inc. - Common Stock publicly traded?
Yes, ClearPoint Neuro Inc. - Common Stock is publicly traded.
What exchange does ClearPoint Neuro Inc. - Common Stock trade on?
ClearPoint Neuro Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ClearPoint Neuro Inc. - Common Stock?
The ticker symbol for ClearPoint Neuro Inc. - Common Stock is CLPT on the Nasdaq Stock Market
What is the current price of ClearPoint Neuro Inc. - Common Stock?
The current price of ClearPoint Neuro Inc. - Common Stock is 15.38
When was ClearPoint Neuro Inc. - Common Stock last traded?
The last trade of ClearPoint Neuro Inc. - Common Stock was at 08/03/26 04:00 PM ET
What is the market capitalization of ClearPoint Neuro Inc. - Common Stock?
The market capitalization of ClearPoint Neuro Inc. - Common Stock is 363.58M
How many shares of ClearPoint Neuro Inc. - Common Stock are outstanding?
ClearPoint Neuro Inc. - Common Stock has 364M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap